158 related articles for article (PubMed ID: 34860146)
21. Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts.
Kato T; Furusawa A; Okada R; Inagaki F; Wakiyama H; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
Mol Cancer Ther; 2023 Jan; 22(1):75-88. PubMed ID: 36223542
[TBL] [Abstract][Full Text] [Related]
22. Near-Infrared Photochemoimmunotherapy by Photoactivatable Bifunctional Antibody-Drug Conjugates Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancer.
Ito K; Mitsunaga M; Nishimura T; Saruta M; Iwamoto T; Kobayashi H; Tajiri H
Bioconjug Chem; 2017 May; 28(5):1458-1469. PubMed ID: 28402624
[TBL] [Abstract][Full Text] [Related]
23. Molecularly Targeted Cancer Combination Therapy with Near-Infrared Photoimmunotherapy and Near-Infrared Photorelease with Duocarmycin-Antibody Conjugate.
Nagaya T; Gorka AP; Nani RR; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Schnermann MJ; Kobayashi H
Mol Cancer Ther; 2018 Mar; 17(3):661-670. PubMed ID: 29237807
[TBL] [Abstract][Full Text] [Related]
24. [Near Infrared Photoimmunotherapy for Cancer].
Kobayashi H
Gan To Kagaku Ryoho; 2019 Jan; 46(1):28-33. PubMed ID: 30765637
[TBL] [Abstract][Full Text] [Related]
25. Near Infrared Photoimmunotherapy: A Review of Recent Progress and Their Target Molecules for Cancer Therapy.
Mohiuddin TM; Zhang C; Sheng W; Al-Rawe M; Zeppernick F; Meinhold-Heerlein I; Hussain AF
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768976
[TBL] [Abstract][Full Text] [Related]
26. Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer.
Katsube R; Noma K; Ohara T; Nishiwaki N; Kobayashi T; Komoto S; Sato H; Kashima H; Kato T; Kikuchi S; Tazawa H; Kagawa S; Shirakawa Y; Kobayashi H; Fujiwara T
Sci Rep; 2021 Jan; 11(1):1693. PubMed ID: 33462372
[TBL] [Abstract][Full Text] [Related]
27. Near-infrared photoimmunotherapy (NIR-PIT) of bone metastases.
Inagaki FF; Wakiyama H; Furusawa A; Okada R; Kato T; Fujimura D; Okuyama S; Fukushima H; Takao S; Choyke PL; Kobayashi H
Biomed Pharmacother; 2023 Apr; 160():114390. PubMed ID: 36791566
[TBL] [Abstract][Full Text] [Related]
28. Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer.
Harada T; Nakamura Y; Sato K; Nagaya T; Okuyama S; Ogata F; Choyke PL; Kobayashi H
Oncotarget; 2016 Nov; 7(48):79408-79416. PubMed ID: 27765903
[TBL] [Abstract][Full Text] [Related]
29. Near infrared photoimmunotherapy using a fiber optic diffuser for treating peritoneal gastric cancer dissemination.
Nagaya T; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Kobayashi H
Gastric Cancer; 2019 May; 22(3):463-472. PubMed ID: 30171392
[TBL] [Abstract][Full Text] [Related]
30. Targeted Phototherapy for Malignant Pleural Mesothelioma: Near-Infrared Photoimmunotherapy Targeting Podoplanin.
Nishinaga Y; Sato K; Yasui H; Taki S; Takahashi K; Shimizu M; Endo R; Koike C; Kuramoto N; Nakamura S; Fukui T; Yukawa H; Baba Y; K Kaneko M; Chen-Yoshikawa TF; Kobayashi H; Kato Y; Hasegawa Y
Cells; 2020 Apr; 9(4):. PubMed ID: 32326079
[TBL] [Abstract][Full Text] [Related]
31. Near-Infrared Photoimmunotherapy Using a Small Protein Mimetic for HER2-Overexpressing Breast Cancer.
Yamaguchi H; Pantarat N; Suzuki T; Evdokiou A
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31757056
[TBL] [Abstract][Full Text] [Related]
32. CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model.
Furusawa A; Okada R; Inagaki F; Wakiyama H; Kato T; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
Oncoimmunology; 2022; 11(1):2019922. PubMed ID: 35003897
[TBL] [Abstract][Full Text] [Related]
33. Near-infrared photoimmunotherapy is effective treatment for colorectal cancer in orthotopic nude-mouse models.
Hollandsworth HM; Amirfakhri S; Filemoni F; Molnar J; Hoffman RM; Yazaki P; Bouvet M
PLoS One; 2020; 15(6):e0234643. PubMed ID: 32555717
[TBL] [Abstract][Full Text] [Related]
34. Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination.
Yasui H; Nishinaga Y; Taki S; Takahashi K; Isobe Y; Sato K
J Vis Exp; 2021 Feb; (168):. PubMed ID: 33645559
[TBL] [Abstract][Full Text] [Related]
35. Near-infrared photoimmunotherapy targeting Nectin-4 in a preclinical model of bladder cancer.
Fukushima H; Takao S; Furusawa A; Valera Romero V; Gurram S; Kato T; Okuyama S; Kano M; Choyke PL; Kobayashi H
Cancer Lett; 2024 Mar; 585():216606. PubMed ID: 38272345
[TBL] [Abstract][Full Text] [Related]
36. MR imaging biomarkers for evaluating therapeutic effects shortly after near infrared photoimmunotherapy.
Nakamura Y; Bernardo M; Nagaya T; Sato K; Harada T; Choyke PL; Kobayashi H
Oncotarget; 2016 Mar; 7(13):17254-64. PubMed ID: 26885619
[TBL] [Abstract][Full Text] [Related]
37. Near-infrared photoimmunotherapy: design and potential applications for cancer treatment and beyond.
Wei D; Qi J; Hamblin MR; Wen X; Jiang X; Yang H
Theranostics; 2022; 12(16):7108-7131. PubMed ID: 36276636
[TBL] [Abstract][Full Text] [Related]
38. Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models.
Maruoka Y; Furusawa A; Okada R; Inagaki F; Fujimura D; Wakiyama H; Kato T; Nagaya T; Choyke PL; Kobayashi H
Cancer Immunol Res; 2020 Mar; 8(3):345-355. PubMed ID: 31953245
[TBL] [Abstract][Full Text] [Related]
39. Near-infrared photoimmunotherapy (NIR-PIT) on cholangiocarcinoma using a novel catheter device with light emitting diodes.
Hirata H; Kuwatani M; Nakajima K; Kodama Y; Yoshikawa Y; Ogawa M; Sakamoto N
Cancer Sci; 2021 Feb; 112(2):828-838. PubMed ID: 33345417
[TBL] [Abstract][Full Text] [Related]
40. HER2 targeting near-infrared photoimmunotherapy for a CDDP-resistant small-cell lung cancer.
Takahashi K; Taki S; Yasui H; Nishinaga Y; Isobe Y; Matsui T; Shimizu M; Koike C; Sato K
Cancer Med; 2021 Dec; 10(24):8808-8819. PubMed ID: 34729945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
